Latest News
Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Estimates – NASDAQ:CTKB
- Cytek Biosciences to report Q3FY26 results on November 4
- Total cash dividends paid of Cytek Biosciences, Inc. – NASDAQ:CTKB
- Cytek Biosciences introduces Cytek cFluor V547 fluorochrome for advanced B cell analysis
- Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- Morgan Stanley keeps USD 5.00 target for Cytek Biosciences stock
- Cytek Biosciences Stock Price Forecast. Should You Buy CTKB?
- Six analysts put Cytek Biosciences stock at USD 5.56
- Cytek Biosciences (CTKB) Q2 2026 Earnings: Narrower-Than-Expected Loss Draws Modest Stock Gain - Guidance Accuracy Score
- Cytek Biosciences (NASDAQ:CTKB) Updates Bylaws Following $56.1 Million Patent Verdict
- Cytek introduces new end-to-end flow cytometry workflow
Headlines from the last 30 days, linking to the original publishers. See all market news →